• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
  

PubMed=11242531; DOI=10.1089/10430340150504019
Ansgar Bruning, Tanja Kohler, Sven Roy Quist, Shan Wang-Gohrke, Volker Jochen Mobus, Rolf Kreienberg, Ingo Bernard Runnebaum;
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphaVbeta3.
Hum. Gene Ther. 12:391-399(2001)

PubMed=11733966; DOI=10.1006/gyno.2001.6425
Volker Jochen Mobus, Claus-Dieter Gerharz, Wolfgang Weikel, Oliver Merk, Liane Dreher, Rolf Kreienberg, Roland Moll;
Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.
Gynecol. Oncol. 83:523-532(2001)

PubMed=11925137; DOI=10.1006/gyno.2002.6597
Matthias Oppitz, Volker Jochen Mobus, S. Brock, Ulrich Drews;
Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients.
Gynecol. Oncol. 85:159-164(2002)

PubMed=15153938; DOI=10.1038/sj.cgt.7700727
Sven Roy Quist, Shan Wang-Gohrke, Tanja Kohler, Rolf Kreienberg, Ingo Bernard Runnebaum;
Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.
Cancer Gene Ther. 11:547-554(2004)